ONIVYDE ema
「ONIVYDE ema」熱門搜尋資訊
![ONIVYDE ema](https://i0.wp.com/api.multiavatar.com/ONIVYDE+ema.png?apikey=viVnb6N20jclO8)
「ONIVYDE ema」文章包含有:「EU311933」、「MA(EU)」、「Onivydepegylatedliposomal(previouslyknownasOnivyde)」、「ONIVYDEPEGYLATEDLIPOSOMAL」、「ONIVYDEpegylatedliposomal」、「ONIVYDEpegylatedliposomal」、「Onivyde」、「Onivyde,INN-irinotecan」、「onivyde-pegylated-liposomal-h-c-psusa」、「智擎(4162)ONIVYDE申請新適應症獲歐洲EMA受理」
查看更多![EU311933](https://api.multiavatar.com/EU311933+%7C+European+Medicines+Agency.png?apikey=viVnb6N20jclO8)
EU311933
https://www.ema.europa.eu
During its meeting of 6-8 September 2016, the Committee for Orphan Medicinal Products (COMP) reviewed the designation EU/3/11/933 for Onivyde (irinotecan1), ...
![MA (EU)](https://api.multiavatar.com/MA+%28EU%29.png?apikey=viVnb6N20jclO8)
MA (EU)
https://www.ema.europa.eu
ONIVYDE pegylated liposomal. 4.3 mg/ml Concentrate for dispersion for infusion. Intravenous use vial (glass). 10 ml. 1 vial.
![Onivyde pegylated liposomal (previously known as Onivyde)](https://api.multiavatar.com/Onivyde+pegylated+liposomal+%28previously+known+as+Onivyde%29.png?apikey=viVnb6N20jclO8)
Onivyde pegylated liposomal (previously known as Onivyde)
https://www.ema.europa.eu
Onivyde pegylated liposomal is a cancer medicine that is used to treat a form of pancreatic cancer called metastatic adenocarcinoma of the pancreas.
![ONIVYDE PEGYLATED LIPOSOMAL](https://api.multiavatar.com/ONIVYDE+PEGYLATED+LIPOSOMAL%2C+INN-IRINOTECAN.png?apikey=viVnb6N20jclO8)
ONIVYDE PEGYLATED LIPOSOMAL
https://www.ema.europa.eu
Treatment of metastatic adenocarcinoma of the pancreas, in combination with 5-fluorouracil (5-FU) and leucovorin (LV), in adult patients who have progressed ...
![ONIVYDE pegylated liposomal](https://api.multiavatar.com/ONIVYDE+pegylated+liposomal%2C+INN-irinotecan+....png?apikey=viVnb6N20jclO8)
ONIVYDE pegylated liposomal
https://www.ema.europa.eu
Onivyde pegylated liposomal is a cancer medicine that is used to treat a form of pancreatic cancer called metastatic adenocarcinoma of the pancreas.
![ONIVYDE pegylated liposomal](https://api.multiavatar.com/ONIVYDE+pegylated+liposomal%2C+INN-irinotecan+anhydrous+free+....png?apikey=viVnb6N20jclO8)
ONIVYDE pegylated liposomal
https://www.ema.europa.eu
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us. Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000.
![Onivyde](https://api.multiavatar.com/Onivyde%2C+INN-Irinotecan+%28pegylated+liposomal+formulation%29.png?apikey=viVnb6N20jclO8)
Onivyde
https://www.ema.europa.eu
The full indication is: Treatment of metastatic adenocarcinoma of the pancreas, in combination with. 5-fluorouracil (5-FU) and leucovorin (LV), ...
![Onivyde, INN-irinotecan](https://api.multiavatar.com/Onivyde%2C+INN-irinotecan+-+European+Medicines+Agency+%7C.png?apikey=viVnb6N20jclO8)
Onivyde, INN-irinotecan
https://www.ema.europa.eu
Reduce ONIVYDE dose to 60 mg/m2. Reduce 5-FU dose by 25% (1800 mg/m2). Page 13. Assessment report. EMA/CHMP/589179/2016. Page 13/107.
![onivyde-pegylated-liposomal-h-c-psusa](https://api.multiavatar.com/onivyde-pegylated-liposomal-h-c-psusa-00010534-202110+....png?apikey=viVnb6N20jclO8)
onivyde-pegylated-liposomal-h-c-psusa
https://www.ema.europa.eu
European Medicines Agency, 2022. Reproduction is authorised provided the source is acknowledged. 23 June 2022. EMA/915538/2022.
![智擎(4162)ONIVYDE申請新適應症獲歐洲EMA受理](https://api.multiavatar.com/%E6%99%BA%E6%93%8E%284162%29ONIVYDE%E7%94%B3%E8%AB%8B%E6%96%B0%E9%81%A9%E6%87%89%E7%97%87%E7%8D%B2%E6%AD%90%E6%B4%B2EMA%E5%8F%97%E7%90%86.png?apikey=viVnb6N20jclO8)
智擎(4162)ONIVYDE申請新適應症獲歐洲EMA受理
https://news.gbimonthly.com
智擎(4162)ONIVYDE申請新適應症獲歐洲EMA受理 · 1.事實發生日:112/07/11 · 2.公司名稱:智擎生技製藥股份有限公司 · 3.與公司關係(請輸入本公司或子公司):本 ...